Solid Biosciences (SLDB) Change in Cash (2017 - 2026)

Solid Biosciences has disclosed Change in Cash across 10 years of filings, most recently posting $236.6 million for Q1 2026.

• Change in Cash for Q1 2026 came in at $236.6 million, up 81.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $85.8 million (down 7.89% YoY), and the FY2025 annual result was -$20.3 million, down 420.19% from the prior year.
• Change in Cash came in at $236.6 million for Q1 2026 at Solid Biosciences, up from -$1.4 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $236.6 million in Q1 2026 to a low of -$77.6 million in Q3 2025.
• The 5-year median for Change in Cash is -$1.4 million (2025), against an average of $10.4 million.
• Across the five-year window, Change in Cash soared 1035.32% in 2022 and plunged 670.37% in 2023, its largest moves.
• Solid Biosciences' Change in Cash stood at $106.4 million in 2022, then slumped by 76.51% to $25.0 million in 2023, then slumped by 36.5% to $15.9 million in 2024, then sank by 108.81% to -$1.4 million in 2025, then surged by 17020.96% to $236.6 million in 2026.
• The last three Change in Cash figures came in at $236.6 million (Q1 2026), -$1.4 million (Q4 2025), and -$77.6 million (Q3 2025), per Business Quant data.